U

University of Pecs | Medical School - Department of Dermatology, Venereology and Oncodermatology

Research site

(Unclaimed)

Location

1 Akac Street, Pecs, Pécs, Hungary

Site insights

Top conditions

Top treatments

Empagliflozin

Octreotide

Dexamethasone

Lenalidomide

BI 690517

rt-PA

Metyrapone

AS1413

Magrolimab

Atezolizumab

Parent organization

This site is a part of University of Pecs

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 30 total trials

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empaglif...

Begins enrollment in 2 months

Chronic Kidney Disease

Drug: Placebo

Drug: Empagliflozin

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling

Hypertension

Cardiovascular Diseases

Drug: Placebo matching Vicadrostat

Drug: Vicadrostat

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

This study is open to adults aged 18 and over who have just had a heart attack. The purpose of this study is to find out whether a medicine called BI...

Enrolling

Myocardial Infarction

Drug: BI 765845

Drug: Placebo matching BI 765845